Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON

Hong Yi Chang, Hsiao-Sheng Liu, Ming-Derg Lai, Yuh-Shyan Tsai, Tzong Shin Tzai, Hong-Lin Cheng, Nan-Haw Chow

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Tumor hypoxia drives metastatic progression, drug resistance, and posttreatment relapses, but how cancer cells adapt and evolve in response to hypoxic stress is not well understood. In this study, we address this question with the discovery that the receptor tyrosine kinase RON translocates into the nucleus of hypoxic cancer cells. In response to hypoxia, nuclear RON interacts with the hypoxia-inducible factor HIF-1α in a manner that relies on RON tyrosine kinase activity, binding to the c-JUN promoter and activating it. Mechanistic investigations revealed unexpectedly that nuclear RON played a more important role in activation of the c-JUN promoter than HIF-1α, leading to increased cell proliferation, survival adaptation, in vitro migration, and tumorigenicity under hypoxic conditions. Taken together, our results pointed to a novel function for RON as a transcriptional regulator that promotes the survival of cancer cells subjected to hypoxia. These results suggest novel implications for the use of small-molecule inhibitors or monoclonal antibodies targeting the RON kinase in the prevention or treatment of advanced cancer.

Original languageEnglish
Pages (from-to)4549-4562
Number of pages14
JournalCancer Research
Volume74
Issue number16
DOIs
Publication statusPublished - 2014 Aug 15

Fingerprint

Protein-Tyrosine Kinases
Neoplasms
Cell Survival
Hypoxia-Inducible Factor 1
Receptor Protein-Tyrosine Kinases
Drug Resistance
rice bran saccharide
Hypoxia
Phosphotransferases
Monoclonal Antibodies
Cell Proliferation
Recurrence

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{1347e1f4ffdc4c1a8dc07074ea0028b4,
title = "Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON",
abstract = "Tumor hypoxia drives metastatic progression, drug resistance, and posttreatment relapses, but how cancer cells adapt and evolve in response to hypoxic stress is not well understood. In this study, we address this question with the discovery that the receptor tyrosine kinase RON translocates into the nucleus of hypoxic cancer cells. In response to hypoxia, nuclear RON interacts with the hypoxia-inducible factor HIF-1α in a manner that relies on RON tyrosine kinase activity, binding to the c-JUN promoter and activating it. Mechanistic investigations revealed unexpectedly that nuclear RON played a more important role in activation of the c-JUN promoter than HIF-1α, leading to increased cell proliferation, survival adaptation, in vitro migration, and tumorigenicity under hypoxic conditions. Taken together, our results pointed to a novel function for RON as a transcriptional regulator that promotes the survival of cancer cells subjected to hypoxia. These results suggest novel implications for the use of small-molecule inhibitors or monoclonal antibodies targeting the RON kinase in the prevention or treatment of advanced cancer.",
author = "Chang, {Hong Yi} and Hsiao-Sheng Liu and Ming-Derg Lai and Yuh-Shyan Tsai and Tzai, {Tzong Shin} and Hong-Lin Cheng and Nan-Haw Chow",
year = "2014",
month = "8",
day = "15",
doi = "10.1158/0008-5472.CAN-13-3730",
language = "English",
volume = "74",
pages = "4549--4562",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON. / Chang, Hong Yi; Liu, Hsiao-Sheng; Lai, Ming-Derg; Tsai, Yuh-Shyan; Tzai, Tzong Shin; Cheng, Hong-Lin; Chow, Nan-Haw.

In: Cancer Research, Vol. 74, No. 16, 15.08.2014, p. 4549-4562.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON

AU - Chang, Hong Yi

AU - Liu, Hsiao-Sheng

AU - Lai, Ming-Derg

AU - Tsai, Yuh-Shyan

AU - Tzai, Tzong Shin

AU - Cheng, Hong-Lin

AU - Chow, Nan-Haw

PY - 2014/8/15

Y1 - 2014/8/15

N2 - Tumor hypoxia drives metastatic progression, drug resistance, and posttreatment relapses, but how cancer cells adapt and evolve in response to hypoxic stress is not well understood. In this study, we address this question with the discovery that the receptor tyrosine kinase RON translocates into the nucleus of hypoxic cancer cells. In response to hypoxia, nuclear RON interacts with the hypoxia-inducible factor HIF-1α in a manner that relies on RON tyrosine kinase activity, binding to the c-JUN promoter and activating it. Mechanistic investigations revealed unexpectedly that nuclear RON played a more important role in activation of the c-JUN promoter than HIF-1α, leading to increased cell proliferation, survival adaptation, in vitro migration, and tumorigenicity under hypoxic conditions. Taken together, our results pointed to a novel function for RON as a transcriptional regulator that promotes the survival of cancer cells subjected to hypoxia. These results suggest novel implications for the use of small-molecule inhibitors or monoclonal antibodies targeting the RON kinase in the prevention or treatment of advanced cancer.

AB - Tumor hypoxia drives metastatic progression, drug resistance, and posttreatment relapses, but how cancer cells adapt and evolve in response to hypoxic stress is not well understood. In this study, we address this question with the discovery that the receptor tyrosine kinase RON translocates into the nucleus of hypoxic cancer cells. In response to hypoxia, nuclear RON interacts with the hypoxia-inducible factor HIF-1α in a manner that relies on RON tyrosine kinase activity, binding to the c-JUN promoter and activating it. Mechanistic investigations revealed unexpectedly that nuclear RON played a more important role in activation of the c-JUN promoter than HIF-1α, leading to increased cell proliferation, survival adaptation, in vitro migration, and tumorigenicity under hypoxic conditions. Taken together, our results pointed to a novel function for RON as a transcriptional regulator that promotes the survival of cancer cells subjected to hypoxia. These results suggest novel implications for the use of small-molecule inhibitors or monoclonal antibodies targeting the RON kinase in the prevention or treatment of advanced cancer.

UR - http://www.scopus.com/inward/record.url?scp=84905964443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905964443&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-13-3730

DO - 10.1158/0008-5472.CAN-13-3730

M3 - Article

C2 - 24903148

AN - SCOPUS:84905964443

VL - 74

SP - 4549

EP - 4562

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 16

ER -